CSC
OGN icon

Caldwell Sutter Capital’s Organon & Co OGN Stock Holding History

Caldwell Sutter Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79K Sell
280
-20
-7% -$239 ﹤0.01% 730
2026
Q1 		$1.8K Buy
300
+25
+9% +$188 ﹤0.01% 767
2025
Q4 		$1.97K Sell
275
-25
-8% -$198 ﹤0.01% 748
2025
Q3 		$3.2K Sell
300
-159
-35% -$1.56K ﹤0.01% 688
2025
Q2 		$4.44K Sell
459
-512
-53% -$5.28K ﹤0.01% 629
2025
Q1 		$14.5K Hold
971
– – 0.01% 504
2024
Q4 		$14.5K Buy
971
+434
+81% +$7.07K 0.01% 514
2024
Q3 		$10.3K Sell
537
-8
-1% -$166 ﹤0.01% 551
2024
Q2 		$11.3K Sell
545
-9
-2% -$179 0.01% 544
2024
Q1 		$10.4K Buy
554
+144
+35% +$2.47K 0.01% 542
2023
Q4 		$5.91K Buy
410
+5
+1% +$68 ﹤0.01% 604
2023
Q3 		$7.03K Sell
405
-341
-46% -$7.11K ﹤0.01% 563
2023
Q2 		$15.5K Buy
746
+275
+58% +$5.98K 0.01% 479
2023
Q1 		$11.1K Buy
471
+324
+220% +$8.7K 0.01% 385
2022
Q4 		$4.11K Buy
+147
New +$3.76K ﹤0.01% 286

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Caldwell Sutter Capital's OGN Position: Q2 2026 in Review

Caldwell Sutter Capital reduced its Organon & Co (OGN) stake by 6.7% in Q2 2026, selling an estimated $239 and leaving 280 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Caldwell Sutter Capital first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.5K in Q2 2023. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Caldwell Sutter Capital held 280 shares of Organon & Co worth $3.79K as of Q2 2026.
  • Caldwell Sutter Capital sold 20 Organon & Co shares in Q2 2026, an estimated $239.
  • Organon & Co made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #730 holding.
  • Caldwell Sutter Capital first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • Caldwell Sutter Capital's Organon & Co position peaked at $15.5K in Q2 2023.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.